can semaglutide cause liver damage GLP-1 medicine improves health independent of weight loss, according to a new Sinai Health & U of T Medicine study ➡️ uoft.me/cjP Wegovy May Halt and Even

Sources and references MHRA / GOV.UK: First GLP-1 tablet for weight loss approved in the UK NHS: Overweight and obesity in adults NICE NG246: Medicines for overweight and obesity New England Journal of Medicine: Oral semaglutide 25 mg in adults with overweight or obesity European Medicines Agency: Wegovy tablets for oral use positive opinion MHRA Drug Safety Update: Semaglutide and NAION MHRA Yellow Card: report a suspected side effect MHRA / GOV.UK: GLP-1 medicines for weight loss and diabetes MHRA Products: official SmPC and patient leaflets UK prescribing decisions should follow UK regulatory information, the prescriber's clinical assessment and the official UK product information when published

Key Takeaways GLP-3RT and retatrutide are the same research compound It is a triple-receptor agonist acting on GLP-1, GIP, and glucagon receptors It is the next-generation step beyond tirzepatide (which is dual: GLP-1 + GIP) and semaglutide (which is single: GLP-1 only) Supplied as a lyophilized synthetic peptide for laboratory research use only For the full ARG Peptides incretin-family research catalog, browse the research peptide shop

How does Retatrutide compare to Mounjaro for men

If anything seems off, contact Belmar customer service before using the medication

Ohn JH, Kwak SH, Cho YM, et al

How Semaglutide Changes Your Appetite and Food Tolerance Semaglutide slows gastric emptyingthe rate at which food moves from your stomach into your small intestine